Chemotherapy chairs are used for multiple purposes such as cancer treatment, autoimmune disease treatment during the infusion process of drugs. There are different type of chairs for patients such as adult chairs, pediatric chairs, bariatric chairs (for obese cancer patients). Increasing donations from the Thunder Bay Regional Health Services Foundation is expected to aid growth of global chemotherapy chairs market. For instance, in November 2013, Lake of the Woods Regional Hospital received an amount of US$ 3,785 to purchase two treatment chairs for the hospital’s chemotherapy clinic, which are designed for patients weighing over 300 pounds. The money is a grant from the Thunder Bay Regional Health Services Foundation, which will allow the hospital to order the special chemotherapy chairs.

The global chemotherapy chairs market size is estimated to be valued at US$ 503.5 million in 2018, and is expected to witness a CAGR of 5.9% over the forecast period (2019 – 2026).

Browse Summary of the Research Report – https://www.coherentmarketinsights.com/market-insight/chemotherapy-chairs-market-2932

Increasing Specialty Centers for Cancer Care is expected to Drive Growth of the Global Chemotherapy Chairs Market

The global chemotherapy chair market size is expected to witness significant growth, owing to increasing number of new cancer care centers where chemotherapy or infusion chairs are frequently used. For instance, in September 2018, Tennessee Oncology, New York Cancer & Blood Specialists, and West Cancer Center in partnership announced the launch of OneOncology a community-based cancer care center across the U.S. It is patient-centric, physician-driven, and technology-powered cancer center with a mission to improve the lives of everyone living with cancer. Furthermore, in June 2019, Arizona Blood & Cancer Specialists announced that they will open six new clinics serving patients in Tucson, Green Valley, Nogales and Safford. Together, OneOncology and Arizona Blood & Cancer Specialists will build multidisciplinary, comprehensive cancer centers to provide an exceptional, personalized experience across the continuum of care from prevention and diagnosis, to clinical trials and treatment, through survivorship, palliative, and supportive care.

Moreover, chemotherapy is also used for treatment of blood disorder, plethora of autoimmune diseases and etc. Therefore, the global chemotherapy chairs market is also expected to increase, owing to increasing prevalence autoimmune diseases worldwide. According to the American Autoimmune Related Diseases Association (AARDA) report of 2017, autoimmune diseases affect 5% to 10% of the global population, particularly women, who are two to ten times more likely to suffer from an AD than men. Some of the autoimmune diseases are within the top 10 leading causes of death among women aged 65 years and above.

There are few hospitals already taking pace in starting new cancer units with high investments on their set up which includes chemotherapy equipment like chairs. For instance, in May 2018, Solihull Haematology and Oncology Day Unit project conducted by Solihull Hospital, managed by managed by University Hospitals Birmingham NHS Foundation, opened their new unit on chemotherapy treatment with an investment of US$ 2.5 million. They mentioned the requirement of 31 patient treatment chairs in the three years in which 24 chairs required in the initial stage. These kind of initiations in the treatment of cancers expected to increase the demand of chemotherapy chairs in the near future.

Global Chemotherapy Chairs Market - Regional Insights

North America is expected to hold a dominant position in the global chemotherapy chairs market during the forecast period, owing to increasing incidences of childhood cancer. For instance, according to the National Cancer Institute (NCI) report of 2018, it is estimated that around 15,590 children and adolescents aged 0 to 19 years were diagnosed with cancer and around 1,780 died of the disease in the U.S. in 2018.

Europe is expected to foresee a rapid growth in the global chemotherapy chairs market. The market in Europe is expected to gain momentum during the forecast period, owing to high presence of key players in the region such as Likamed GmbH, GREINER GmbH, and Bionic Medizintechnik GmbH. These are Germany-based companies, incorporated with advanced technology. Moreover, BMB Medical and Earthlite Medical are also Europe-based companies.

Key players operating in the global chemotherapy chairs market include BMB Medical, Earthlite Medical, Nanning Passion Medical Equipment, Likamed GmbH, GREINER GmbH, Bionic Medizintechnik GmbH, and Paramount Bed Co. Ltd.

Request A Sample Copy - https://www.coherentmarketinsights.com/insight/request-sample/2932

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
**********************************************************************************************